Article info
Original articles
Cystic fibrosis
Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study
- Correspondence to Dr David Taylor-Robinson, MRC Population Health Scientist, Department of Public Health and Policy, Whelan Building, University of Liverpool, Liverpool L69 3GB, UK; dctr{at}liv.ac.uk
Citation
Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study
Publication history
- Received August 15, 2011
- Accepted February 26, 2012
- First published May 3, 2012.
Online issue publication
September 01, 2022
Article Versions
- Previous version (29 July 2016).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Download Supplementary Data (PDF) - Manuscript file of format pdf
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.